Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.4 USD | -1.63% | -2.28% | -10.80% |
May. 01 | RBC Trims Exelixis' Price Target to $27 From $28, Outperform Rating Kept | MT |
Apr. 30 | Exelixis Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Maintained -- Shares Fall After Hours | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.80% | 6.34B | |
+3.74% | 108B | |
+11.17% | 104B | |
+1.28% | 22.33B | |
-12.72% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.47% | 17.64B | |
+3.77% | 14.05B | |
+37.52% | 12.51B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Exelixis Appoints Amy Peterson as Chief Medical Officer